Investment Rating - The report maintains the full-year performance guidance unchanged for Giant Biogene, indicating confidence in the company's ability to recover revenue growth in the latter half of the year [10][11]. Core Insights - The recombinant collagen industry is in its early development stage, lacking unified testing and quality standards, which affects the accuracy of testing results [2][7]. - The company experienced a controllable impact on its online business during the 618 sales period, with sales of its Comfy brand ranking second in Tmall's domestic beauty products [8]. - The offline business remained stable, with strong performance in hospitals and pharmacies, unaffected by recent public opinion events [9]. - The company plans to enhance brand communication and consumer trust through various initiatives, including transparent communication and collaboration with research institutions [12]. - Future online marketing strategies will focus on "people, goods, and places," aiming to improve customer engagement and brand exposure [13]. Summary by Sections Business Update - The company discussed recent public opinion events and their impact on operations during the June 24, 2025, meeting [6]. - The online sales of Comfy were initially affected by a public opinion event but returned to normal levels shortly after [8]. - Offline sales of major medical device products remained strong, supporting stable business development [9]. Financial Performance - The profit margin in the first half of 2025 was not adversely affected by public opinion events, with a positive impact from the increase in offline business proportion [11]. - The company is confident in recovering revenue growth in the third and fourth quarters through refined operations and continuous investment [10]. Future Strategies - The company aims to strengthen brand and consumer communication to enhance trust and loyalty [12]. - Marketing efforts will include differentiated offerings for new and existing customers, leveraging the professionalism of medical devices [13].
巨子生物（02367）：巨子生物近况更新